Back

Metabolic Basis of Post-Infectious Sequelae After Ebola Virus Disease

Sanford, A. C.; Bond, N. G.; Ficenec, S.; Osterman, C.; Farkas, P.; Engel, E. J.; Gunn, B. M.; Grant, D. S.; Samuels, R. J.; Zwezdaryk, K.; Schieffelin, J. S.

2026-01-06 infectious diseases
10.64898/2026.01.02.25343095 medRxiv
Show abstract

Ebola virus disease (EVD) survivors often present with clinical sequelae after acute disease resolution, called post-Ebola syndrome (PES). Why some survivors develop these sequelae and others do not is poorly defined. Altered metabolism has been noted in acute EVD but not studied in PES. We identified differential expression of metabolites involved in multiple metabolic pathways in EVD survivors with PES. This included the tricarboxylic acid cycle, amino acid, nucleotide, and short chain fatty acid metabolism. Several of these pathways are associated with immune dysfunction. The identified metabolites have potential use as biomarkers of post-Ebola syndrome.

Matching journals

The top 16 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.